SERUM LEVELS OF HEMOPOIETIC AND ANGIOGENESIS GROWTH FACTORS (IL-5, IL-7, IL-9, FGF-β, G-CSF, VEGF AND PDGF) IN WOMEN WITH UTERINE MYOMA
Authors:
Open Access
- 6 November 2018
- journal article
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 20 (5) , 691-698
Abstract
Uterine leiomyomas are common benign tumors developing from smooth muscle tissues, often leading to infertility and recurrent abortions. Pregnancy and development of uterine fibroids are characterized by an unusual rate of myometrium growth, hyperproduction of extracellular matrix and increased expression of numerous growth factor receptors. The purpose of this study was to determine concentrations of some key growth factors (IL-5, IL-7, IL-9, FGF-β, G-CSF, VEGF and PDGF) in blood serum of women with uterine myoma. Concentrations of the 27 cytokines were determined using a Bio Rad kit (USA) – Bio-Plex Pro™. Human Cytokine 27-plex Assay by means of flow-through fluorometry at the Bio-Plex 200 double-beam laser analyzer. Thirty-six patients with verified uterine myoma were followed up, being later subject to operative treatment (laparoscopic myomectomy). The results of this study showed a trend to decreased amounts of some hematopoiesis and angiogenesis growth factors, e.g., IL-9 and FGF, in blood serum of women with uterine myoma. Сoncentrations of IL-5, IL-7, and G-CSF proved to be significantly decreased if compared to serum contents of European healthy women. The most significant decrease was registered for pro-angiogenic factors, such as VEGF and PDGF. Their serum concentration in women with leiomyoma was reduced, respectively, 3- and 6-fold against controls. The decreased G-CSF concentration was not only quite significant, as compared to healthy women, but showed significant correlations with changes of such factors as IL-5, IL-7 and IL-9, with correlation quotients of, resp., 0.723, 0.637, and 0.504, respectively. One may conclude that, in spite of literature data on significantly increased contents of the mentioned growth factors in tissues of myometrium and growing uterine leiomyoma, our data show that the concentrations of these regulatory proteins in blood serum are decreased to some extent in this clinical condition.Keywords
This publication has 21 references indexed in Scilit:
- Disrupted fibroblastic reticular cells and interleukin-7 expression in tumor draining lymph nodesOncology Letters, 2017
- GM-CSF: From Growth Factor to Central Mediator of Tissue InflammationImmunity, 2016
- Roles of FGF Signals in Heart Development, Health, and DiseaseFrontiers in Cell and Developmental Biology, 2016
- The development and in vivo function of T helper 9 cellsNature Reviews Immunology, 2015
- Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implicationsHuman Reproduction Update, 2011
- Activin-A and Myostatin Response and Steroid Regulation in Human Myometrium: Disruption of Their Signalling in Uterine FibroidThe Journal of Clinical Endocrinology & Metabolism, 2011
- Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor β-3Fertility and Sterility, 2010
- Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcomaInternational Journal of Gynecological Cancer, 2005
- Biology of platelet‐derived growth factors in developmentBirth Defects Research Part C: Embryo Today: Reviews, 2003
- Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma.International Journal of Molecular Medicine, 2001